Maintenance antipsychotic trials and the effect of withdrawal

Affiliations

¹ Centre for Evidence-Based Medicine Odense and Cochrane Denmark, Department of Clinical Research, University of Southern Denmark, Odense 5000, Denmark; Open Patient data Exploratory Network, Odense University Hospital, Odense, Denmark. Electronic address: kmunkholm@health.sdu.dk.
² Research and Development Department, Goodmayes Hospital, North East London NHS Foundation Trust, Ilford, UK; Division of Psychiatry, University College London, London, UK.

Comment

Klaus Munkholm et al. Lancet. 2022.

. 2022 Sep 24;400(10357):995.

doi: 10.1016/S0140-6736(22)01467-2.

¹ Centre for Evidence-Based Medicine Odense and Cochrane Denmark, Department of Clinical Research, University of Southern Denmark, Odense 5000, Denmark; Open Patient data Exploratory Network, Odense University Hospital, Odense, Denmark. Electronic address: kmunkholm@health.sdu.dk.
² Research and Development Department, Goodmayes Hospital, North East London NHS Foundation Trust, Ilford, UK; Division of Psychiatry, University College London, London, UK.

No abstract available

Comment in

Maintenance antipsychotic trials and the effect of withdrawal - Authors' reply.
Schneider-Thoma J, Siafis S, Leucht S. Schneider-Thoma J, et al. Lancet. 2022 Sep 24;400(10357):995-996. doi: 10.1016/S0140-6736(22)01442-8. Lancet. 2022. PMID: 36154689 No abstract available.

Comparative efficacy and tolerability of 32 oral and long-acting injectable antipsychotics for the maintenance treatment of adults with schizophrenia: a systematic review and network meta-analysis.
Schneider-Thoma J, Chalkou K, Dörries C, Bighelli I, Ceraso A, Huhn M, Siafis S, Davis JM, Cipriani A, Furukawa TA, Salanti G, Leucht S. Schneider-Thoma J, et al. Lancet. 2022 Feb 26;399(10327):824-836. doi: 10.1016/S0140-6736(21)01997-8. Lancet. 2022. PMID: 35219395